Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
236,234,693
-
Total 13F shares
-
7,180,472
-
Share change
-
+7,076,001
-
Total reported value
-
$199,536,396
-
Price per share
-
$27.79
-
Number of holders
-
50
-
Value change
-
+$197,487,337
-
Number of buys
-
49
-
Number of sells
-
3
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q2 2014
As of 30 Jun 2014,
Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,180,472 shares.
The largest 10 holders included
Novo A/S, FMR LLC, HealthCor Management, L.P., RA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, STIFEL FINANCIAL CORP, Cormorant Asset Management, LLC, MORGAN STANLEY, BlackRock Fund Advisors, and JENNISON ASSOCIATES LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.